Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.. Caris Life Sciences has now raised $1.86 billion in capital since 2018.

Caris saw year-over-year revenue growth of about 50%, to $120.9 million, in the first quarter of 2025, driven primarily by its molecular profiling services, according to a securities filing.

For most medtech startups, the dream of raising a billion dollars is nothing but a castle in the air. | The new funding values Caris at more than $7.8 billion and brings its total external funding ...

Caris Life Sciences announced plans to go public, testing a technology initial public offering market that’s been frozen over for most of the year.. The Irving-based AI diagnostic company said ...